{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:16:04Z","timestamp":1728101764925},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,10,1]]},"DOI":"10.2169\/internalmedicine.3033-23","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T22:13:18Z","timestamp":1708294398000},"page":"2637-2640","source":"Crossref","is-referenced-by-count":0,"title":["A Family with Familial Hypobetalipoproteinemia Caused by a c.1468C&gt;T in &lt;i&gt;APOB&lt;\/i&gt;"],"prefix":"10.2169","volume":"63","author":[{"given":"Hayato","family":"Tada","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Bredefeld C, Hussain MM, Averna M, et al. Guidance for the diagnosis and treatment of hypolipidemia disorders. J Clin Lipidol 16: 797-812, 2022.","key":"1","DOI":"10.1016\/j.jacl.2022.08.009"},{"doi-asserted-by":"publisher","unstructured":"2. Raal FJ, Santos RD, Blom DJ, et al. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet 375: 998-1006, 2010.","key":"2","DOI":"10.1016\/S0140-6736(10)60284-X"},{"unstructured":"3. Schwartz GG, Steg PG, Szarek M, et al.; the ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med 379: 2097-2107, 2018.","key":"3"},{"doi-asserted-by":"crossref","unstructured":"4. Raal FJ, Rosenson RS, Reeskamp LF, et al.; the ELIPSE HoFH Investigators. Evinacumab for homozygous familial hypercholesterolemia. N Engl J Med 383: 711-720, 2020.","key":"4","DOI":"10.1056\/NEJMoa2004215"},{"doi-asserted-by":"crossref","unstructured":"5. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. Curr Opin Lipidol 31: 49-55, 2020.","key":"5","DOI":"10.1097\/MOL.0000000000000663"},{"doi-asserted-by":"crossref","unstructured":"6. Burnett JR, Zhong S, Jiang ZG, et al. Missense mutations in <i>APOB<\/i> within the \u03b2\u03b11 domain of human APOB-100 result in impaired secretion of apoB and apoB-containing lipoproteins in familial hypobetalipoproteinemia. J Biol Chem 282: 24270-24283, 2007.","key":"6","DOI":"10.1074\/jbc.M702442200"},{"doi-asserted-by":"crossref","unstructured":"7. Burnett JR, Shan J, Miskie BA, et al. A novel nontruncating <i>APOB<\/i> gene mutation, R463W, causes familial hypobetalipoproteinemia. J Biol Chem 278: 13442-13452, 2003.","key":"7","DOI":"10.1074\/jbc.M300235200"},{"doi-asserted-by":"crossref","unstructured":"8. Tada H, Kawashiri MA, Nohara A, et al. Lipoprotein metabolism in familial hypercholesterolemia: serial assessment using a one-step ultracentrifugation method. Pract Lab Med 1: 22-27, 2015.","key":"8","DOI":"10.1016\/j.plabm.2015.03.001"},{"doi-asserted-by":"crossref","unstructured":"9. Tada H, Kawashiri MA, Nomura A, et al. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol 12: 1436-1444, 2018.","key":"9","DOI":"10.1016\/j.jacl.2018.08.006"},{"doi-asserted-by":"publisher","unstructured":"10. Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581: 434-443, 2020.","key":"10","DOI":"10.1038\/s41586-020-2308-7"},{"doi-asserted-by":"crossref","unstructured":"11. Richards S, Aziz N, Bale S, et al.; the ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17: 405-424, 2015.","key":"11","DOI":"10.1038\/gim.2015.30"},{"doi-asserted-by":"publisher","unstructured":"12. Cefal\u00f9 AB, Norata GD, Ghiglioni DG, et al. Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature. Atherosclerosis 239: 209-217, 2015.","key":"12","DOI":"10.1016\/j.atherosclerosis.2015.01.014"},{"doi-asserted-by":"crossref","unstructured":"13. Str\u00f8m TB, Asprusten E, Laerdahl JK, et al. Missense mutation <i>Q384K<\/i> in the <i>APOB<\/i> gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine. J Clin Lipidol 17: 800-807, 2023.","key":"13","DOI":"10.1016\/j.jacl.2023.08.009"},{"doi-asserted-by":"crossref","unstructured":"14. Henry Z, Janin A, Nony S, et al. Interest of minigene splicing reporter assay in familial hypobetalipoproteinemia genetic diagnosis: the example of the missense mutation <i>APOB<\/i> c.1468C&gt;T. Clin Chem Lab Med 61: e259-e262, 2023.","key":"14","DOI":"10.1515\/cclm-2023-0330"},{"doi-asserted-by":"crossref","unstructured":"15. Ayoub C, Azar Y, Abou-Khalil Y, et al. Identification of a variant in <i>APOB<\/i> gene as a major cause of hypobetalipoproteinemia in Lebanese families. Metabolites 11: 564, 2021.","key":"15","DOI":"10.3390\/metabo11090564"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/19\/63_3033-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T03:30:56Z","timestamp":1728099056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/19\/63_3033-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":15,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3033-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"article-number":"3033-23"}}